PAVmed is a medical device company employing a business model to bring innovative products from concept to commercialization with speed and capital efficiency, while enhancing and accelerating value creation.
PAVmed is building a deep pipeline of products encompassing a broad spectrum of clinical areas possessing attractive regulatory pathways and market opportunities currently exceeding $4 billion. The company currently has five lead products to provide multiple near-term value creation opportunities
The Company is led by a team of accomplished medical device entrepreneurs. The leadership team has previously successfully implemented its unique business model of creating value with modest capital investment in four single-product companies, each of which rapidly advanced towards commercialization. Two of these four products have been cleared and commercialized, while two products are currently undergoing FDA review. PAVmed leverages this unique business model.
By establishing a long-term multi-product company with access to public capital, the company plans to build an expanding pipeline of innovative products across a range of specialties and clinical conditions.
Recent Press Releases
8/14/18 7:30 am EDTPAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported financial results for the three and six months ended June 30, 2018 and provided a business update. Management Commentary “I am delighted to report that the second quarter of 2018 was very productive for PAVmed,” said Lishan Aklog., M.D., PAVmed’s Chairman and Chief Executive Officer. “We added the groundbreaking EsoCheck™ technology to ourmore...
8/9/18 7:30 am EDTPAVMED INC. TO HOLD SECOND QUARTER FINANCIAL RESULTS AND BUSINESS UPDATE CONFERENCE CALL ON AUGUST 22, 2018PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company will report second quarter financial results on or before August 14, 2018 and host a conference call on Wednesday, August 22, 2018 at 4:30 p.m. Eastern time. During the call, Lishan Aklog, M.D., Chairman and Chief Executive Officer of the Company, will provide a business update including an overview of the Company’s near-term milestonesmore...
7/25/18 7:30 am EDTPAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided its most recent update on its business.“Since our last business update less than one month ago, we have experienced a strong surge of investor interest in PAVmed and our products,” said Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer. “We remain strongly committed to transparency and robust investor communications, and in that spirit, Imore...
Events & Presentations
In the News
GenomeWeb5/29/18 9:31 am EDT
Forbes11/7/16 5:13 pm EST